Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 15:212:113125.
doi: 10.1016/j.ejmech.2020.113125. Epub 2020 Dec 31.

Novel cyanothiouracil and cyanothiocytosine derivatives as concentration-dependent selective inhibitors of U87MG glioblastomas: Adenosine receptor binding and potent PDE4 inhibition

Zafer Sahin  1 , Sevde Nur Biltekin  2 , Leyla Yurttas  3 , Barkin Berk  2 , Yağmur Özhan  4 , Hande Sipahi  4 , Zhan-Guo Gao  5 , Kenneth A Jacobson  5 , Şeref Demirayak  2
Affiliations

Novel cyanothiouracil and cyanothiocytosine derivatives as concentration-dependent selective inhibitors of U87MG glioblastomas: Adenosine receptor binding and potent PDE4 inhibition

Zafer Sahin et al. Eur J Med Chem. .

Abstract

Thiouracil and thiocytosine are important heterocyclic pharmacophores having pharmacological diversity. Antitumor and antiviral activity is commonly associated with thiouracil and thiocytosine derivatives, which are well known fragments for adenosine receptor affinity with many associated pharmacological properties. In this respect, 33 novel compounds have been synthesized in two groups: 24 thiouracil derivatives (4a-x) and 9 thiocytosine derivatives (5a-i). Antitumor activity of all the compounds was determined in the U87 MG glioblastoma cell line. Compound 5e showed an anti-proliferative IC50 of 1.56 μM, which is slightly higher activity than cisplatin (1.67 μM). The 11 most active compounds showed no signficant binding to adenosine A1, A2A or A2B receptors at 1 μM. Brain tumors express high amounts of phosphodiesterases. Compounds were tested for PDE4 inhibition, and 5e and 5f showed the best potency (5e: 3.42 μM; 5f: 0.97 μM). Remakably, those compounds were also the most active against U87MG. However, the compounds lacked a cytotoxic effect on the HEK293 healthy cell line, which encourages further investigation.

Keywords: Adenosine; Antitumor; HEK293; MCF7; PDE; Phosphosdiesterase; Thiocytosine; Thiouracil; U87.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest There is not any conflict of interest by the authors.

Figures

Figure 1.
Figure 1.
Synthesized compounds and pharmacologically active molecules bearing the same fragments.
Figure 2.
Figure 2.
1H NMR interpretation summary of the compounds
Figure 3.
Figure 3.
Effect of increasing concentrations of 5b–i on viability of U87MG cells.
Figure 4.
Figure 4.
Logaritmic curves of active compounds on PDE assay
Figure 5.
Figure 5.
Graphical representation of IC50 values on all tested cell lines. An HEK293 bar is not given for 5d and 5e because the viability was more than 50%, even at 100 μM, and therefore IC50 values could not be calculated.
Scheme 1.
Scheme 1.
Synthesis of the compounds 1a–c (i: aryl thioamide, 3-chloro-2,4-pentandione, EtOH, reflux 8 h, NaOAc; ii: product of i, CHCl3,0°C, Br2, r.t. 12 h, 30 min at 40°C
Scheme 2.
Scheme 2.
Synthesis of the compounds 2a–h and 3a–c (i: aldehyde, thiourea, K2CO3, ethyl cyanoacetate, EtOH, reflux 16h; ii: aldehyde, thiourea, K2CO3, malononitrile, EtOH, reflux 5h)
Scheme 3.
Scheme 3.
Synthesis of the compounds 4a–x and 5a–i (i: 2a–h, 1a–c, acetone, K2CO3, r.t. 12h, reflux 1 h, i: 3a–c, 1a–c, acetone, K2CO3, r.t. 8 h, reflux 1 h).
See this image and copyright information in PMC

References

    1. Jacobson KA, Jarvis MF, Williams M, Purine and pyrimidine (P2) receptors as drug targets, J. Med. Chem, 45 (2002) 4057–4093. 10.1021/jm020046y. - DOI - PubMed
    1. Abbas SE, Awadallah FM, Ibrahin NA, Said EG, Kamel GM, New quinazolinone-pyrimidine hybrids: synthesis, anti-inflammatory, and ulcerogenicity studies, Eur. J. Med. Chem, 53 (2012) 141–149. 10.1016/j.ejmech.2012.03.050. - DOI - PubMed
    1. Sharma AK, Mahajan MP, Synthesis and [4+2] cycloaddition reactions of 4-(N-allyl-N-aryl)amino-1,3-diaza-1,3-butadienes with vinyl-, isopropenyl- and chloroketenes: Entry to novel pyrimidinone/fused pyrimidinone derivatives., Tetrahedron, 53 (1997) 13841–13854. 10.1016/S0040-4020(97)00873-9. - DOI
    1. Patel A, Pasha Y, Modi A, Synthesis and biological evaluation of 4-aryl substituted −2-(5-carboxylicacid-1, 6-dihydro)-2-thiophenylethylene-6-oxopyrimidine as protein tyrosine phosphatase (PTP-1B) inhibitors, Int. J. Pharmtech. Res, 8 (2015) 136–143. ISSN: 0974–4304.
    1. Abbas SE, Aly EI, Awadallah FM, Mahmoud WR, 4-Substituted-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine derivatives: design, synthesis, antitumor and EGFR tyrosine kinase inhibitory activity, Chem. Biol. Drug Des, 85 (2015) 608–622. 10.1111/cbdd.12451. - DOI - PubMed

MeSH terms